Category: CannabisNewsWire Release

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adapts Operations, Aggressively Reduces Costs While Expanding Product Portfolio

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, on Wednesday announced that, due to market conditions, it is adapting operations and aggressively reducing costs. According to the update, the company has postponed the startup of its Valleyfield facility in order to centralize cultivation operations at Ancaster. The Ontario facility is able to produce larger volumes than initially anticipated, enabling the company to delay Valleyfield cultivation operations while saving costs and capital. “Multiple factors, most particularly the COVID-19 pandemic, are contributing to an environment in which we must be extremely prudent with how we manage our cost structure. These are unprecedented times, and the situation continues to evolve. With the support and unity, I have seen from our employees, partners and stakeholders, I am very confident that TGOD can tackle this challenge and come out much stronger,” TGOD CEO Brian Athaide said in the news release. “We have seen very strong consumer and medical patient feedback from our recent TGOD Infusers launch and are looking forward to having them available in more stores quickly. These along with our upcoming additional 2.0 products are very unique and deliver superior consumer experiences which will help further differentiate and build our TGOD organic brand positioning.”

To view the full press release, visit http://cnw.fm/2MtpR

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) is a premium, certified-organic cannabis company focused on the health and wellness market. Its certified-organic cannabis is grown in living soil, as nature intended. The company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are built to LEED certification standards, and its products are sold in recyclable packaging. In Canada, TGOD plans to expand its product portfolio by launching a series of next-generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the company also distributes premium hemp-CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Honolulu Marijuana Processor to Make Free Hand Sanitizer

When the Coronavirus first appeared in Wuhan, China late last year, no one expected it to have such a worldwide impact. A little more than two months after the virus started ravaging China, it has spread to most continents, infected more than 150,000 and left at least 9,000 people dead. Naturally, most countries are focused on containment efforts, and one of them is calling on people to maintain high levels of hygiene.

The virus spreads through droplets, and one of the best ways to prevent infection is thorough and constant hand washing. However, with massive numbers of people buying hand sanitizers in bulk, shortages were inevitable.

A Hawaiian cannabis company has stepped in to fill this void by providing free hand sanitizers to its clients. Aloha Green Holdings, which does business as Aloha Green Apothecary, has announced that it will “use its cannabis concentrates production line to produce large quantities of hydroalcoholic gels immediately.”

The cannabis firm operates the largest state of the art cannabis manufacturing lab in Hawaii, and it will use these facilities to manufacture free hand sanitizing gel to 329 card holding patients at its two dispensaries. Regulations require patients to have a 329 card to enter a cannabis retail dispensary.

Each patient will be limited to one 50ml bottle per day until Aloha Green ramps up its production. The firm has stated that its intention is to dedicate enough manufacturing lines to produce free hand sanitizers for Oahu’s first responders.

Data from the Department of Health’s Medical Cannabis Registry Program shows that the average age of registered medical cannabis patients in Hawaii is approximately 52. Most of them have underlying medical conditions including cancer, HIV/AIDS, epilepsy, and Multiple Sclerosis, making them especially vulnerable to Covid-19.

“All our locations have a supply of hand sanitizer solution for employee and patient use. We have increased our sanitation procedures. Due to recent reports of hoarding, outages and low supplies in Hawaii, we have decided to manufacture and provide bottles of hand sanitizer free of charge to vulnerable patients who are at increased risk,” says Aloha Green Apoth spokesman TY Cheng.

Aloha Green Apoth CEO James Lee adds that “supporting our local community is a foundational goal for our company. Our cannabis medicines provide essential relief for many patients and we hope patients will continue to feel safe at our dispensaries.”

The firm reminds people that although using a 60%-plus alcohol-based solution is effective, health authorities say that using soap and water is still the most effective method to clean your hands and avoid infection.

Experts say the example set by Aloha Green Apothecary is one that paints the entire cannabis industry, including Champignon Brands Inc. (CSE: SHRM), in good light as sector players are seen as going above and beyond to be helpful to the communities they serve.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – How Marijuana Retailers Can Adapt to the COVID-19 Pandemic

Most of us have never seen or experienced a disease of such epic proportions as the novel Coronavirus. Just a few months after it first appeared, the virus has infected over 150,000 people worldwide and left at least 10,000 dead. According to experts, the virus may end up infecting up to 70% of the world’s population if it continues spreading unabated.

In response, governments all over the world have ordered lockdowns of varying degrees. Since the virus is transmitted through droplets from coughs and sneezes, self-isolation and social distancing are the top preventive measures. This, coupled with constant and thorough hand washing with soap and water or an alcohol-based hand sanitizer is the best way to avoid infection.

Group gatherings are discouraged and all but the most essential businesses have to be closed. For many states, licensed marijuana dispensaries have been lucky to make the cut.

However, with the measures put forth by authorities in response to the pandemic, these businesses will have to adapt to keep both the staff and customers safe. For starters,

Prioritize online bookings. Large gatherings are the virus’ best friend, and people are advised to stay six feet away from each other. This, however, makes shopping in small dispensaries impossible. Online platforms are the best alternative as they allow customers to remotely book their purchase then pop over to the dispensary for a quick pickup.

Curbside pickups are another measure introduced to limit physical contact by states like California, Oregon, Illinois and Michigan. Customers remain in their vehicles, and an employee will bring out your order. Curbside pickups coupled with online bookings will result in a much more efficient and sterile transaction.

Even better, deliver. The best way to prevent congestion at the dispensary is to deliver. While this may require some resources if a delivery system isn’t already in place, it will be a lifesaver during long periods of self-isolation. Customers will want to buy from sellers who deliver right to their doorstep. It completely limits contact or even proximity to large groups, and if the driver takes proper precautions, the entire process will stay as sterile as possible.

While we all hope this pandemic wraps up as soon as possible, it’s more likely the virus will be with us for a while, and the lockdowns even longer. These measures will help marijuana retailers weather the storm that’s sure to come.

It wouldn’t be surprising to learn that cannabis companies like SinglePoint Inc. (OTCQB: SING) are already thinking of ways to adapt to the crisis in order to stay afloat and safeguard customers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces Revolutionary New Class of Hemp Extract Infusion Technologies – EZ Hemp Infusions

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a revolutionary new class of hemp extract infusion technologies designed to make hemp infusions simple for both small and large beverage manufacturers. According to the update, the company’s EZ Hemp Infusions product line is based on patented and patent pending 100% water-soluble technology enabling ultra-low doses to hemp extracts and cannabinoids to be utilized. “The days of beverage manufacturers struggling with high dose hemp extracts and cannabinoids infusion technologies are over,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “Manufacturers do not need to add dozens of milligrams of cannabinoids to beverage and struggle with all of the chemicals that are required to stabilize the infusions. With EZ Hemp Infusions, manufacturers can now simply add our 100% water-soluble products to beverages while still being able to print a clean label that contains no chemicals, surfactants or emulsifiers.”

To view the full press release, visit http://cnw.fm/U2mfD

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Appoints Ernst & Young 2018 Entrepreneur of the Year in Health Care to Special Advisory Committee

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee. According to the update, Dr. Gabriele, PhD, specializes in the areas of molecular pharmacology, transdermal delivery and formulation chemistry with pharmaceutical, natural molecules and will champion the company’s development and commercialization of rapid onset treatments capable of improving health outcomes. “Dr. Gabriele’s established research credentials, entrepreneurial nature and relentless pursuit of medical innovation represents the desired skill sets that Champignon needs as we accelerate our accession into the psychedelic medicine arena,” Champignon Brands CEO Gareth Birdsall said in the news release. “The appointment of Dr. Gabriele equips us with both a celebrated medical researcher, as well as a seasoned CPG formulation specialist, which will allow for the continued development of our mushroom-infused health products, novel delivery systems and eventual drug discovery initiatives. Champignon Brands is set to emerge as an impact investment that may not only change people’s lives but may also revolutionize the face of medicine as we know it today.”

To view the full press release, visit http://cnw.fm/t88RN

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a research driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes for indications such as depression and Post Traumatic Stress Disorder (“PTSD”), as well as substance and alcohol use disorders. Champignon continues to be inspired by sustainability, as its medicinal mushroom infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Webcast Live at March 26 Life Sciences Investor Forum

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Tuesday announced that its Chief Executive Officer, Chris Bunka, will present live at LifeSciencesInvestorForum.com on March 26. According to the update, Bunka’s presentation is scheduled to begin at 12:00 PM ET. The live, interactive online event invites investors to ask the company questions in real-time. It is suggested that interested parties pre-register and run the online system check to expedite participation and receive event updates. An archived webcast will be made available after the event for those unable to join live on the day of the conference.

To register and view event details, visit http://cnw.fm/t9NR1

To view the full press release, visit http://cnw.fm/5tmXo

About Lexaria Bioscience

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way API’s enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactive molecules including nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and other molecules. Lexaria has licensed DehydraTECH to multiple companies for use in various oral application formats, including to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Coronavirus Outbreak Prompts Nebraska Medical Marijuana Advocates to Halt Campaign

In late 2019, the novel Coronavirus, dubbed COVID-19, first appeared in Wuhan, China, and the country literally ground to a halt. The most hard-hit regions went into lockdowns to prevent the spread of the virus, but it also drastically reduced the county’s manufacturing output. Since China is a known low-cost producer, tons of industries were affected by this disruption in manufacturing, including the cannabis sector.

However, now that the virus has spread to most other continents except Antarctica, supply chain disruptions are only one of many issues we should be worrying about. With all but essential businesses ordered to close and millions of people told to self-isolate, there’s so much more to lose.

In Nebraska, for instance, activists announced on Thursday that they were temporarily suspending signature gathering for a campaign to legalize marijuana in the state. This is just one of the instances where drug policy reform efforts have been hampered by the Coronavirus, with some activists requesting emergency action to allow for alternative means to put the measures on state ballots.

“Thank you to all Nebraskans who have given their support so far to get voter approval of legalized medical cannabis on the ballot box this fall. Your signatures, along with overwhelming citizen support for the measure is going to help make it a reality and bring relief to individuals and communities throughout our entire state,” said Nebraskans for Medical Marijuana in a Facebook post.

Due to current circumstances, it is resigned to the fact that it will have to press pause for now. “Out of an abundance of caution and following the wider recommendations from public health officials, we are going to pause our volunteer and paid signature-gathering efforts within local community gathering places until the state indicates it is responsible to continue.”

“We look forward to the opportunity to get back out there to help Nebraskans create meaningful change for each other, and we wish your loved ones health and peace of mind right now,” the press release concludes.

The proposed amendment would allow doctors to recommend cannabis to patients suffering from predetermined medical conditions. They would also be allowed to possess, purchase and ‘discreetly’ cultivate marijuana for personal use.

The activists have to collect about 130,000 signatures by July 8 for the measure to qualify for the November ballot, although it is not clear how many signatures they have already collected or how long they will continue in-person signature gathering.

Experts believe that while marijuana industry players like MCTC Holdings Inc. (OTC: MCTC) are glad that the campaigners have taken the cautious step of halting signature gathering, it is hoped that the pandemic will end in time to give Nebraskans a chance to vote on the legalization of medical marijuana in the state.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – DEA Announces Plan to License More Marijuana Producers for Research

In a move that’s sure to lift some moods in these trying times, the Drug Enforcement Administration (DEA) recently announced that it will be taking steps to expand the scope of marijuana research. The rule changes proposed by the agency will allow it to approve additional cannabis growers and diversify the types of marijuana available for use in studies.

“The Drug Enforcement Administration continues to support additional research into marijuana and its components, and we believe registering more growers will advance the scientific and medical research already being conducted,” said the Acting Administrator Uttam Dhillon in a press release.

“DEA is making progress to register additional marijuana growers for federally authorized research, and will continue to work with other relevant federal agencies to expedite the necessary next steps.”

Back in 2016, the DEA announced that it was accepting applications for additional marijuana manufacturers, and 37 institutions submitted their applications. However, the agency was slow to review the applications, and one of the applicants filed and won a lawsuit that mandated the DEA to take action.

The DEA argued that the high volume of applications, coupled with the complications arising from international drug treaties which the U.S. is a party to, meant they would have to develop new regulations before approving the applications.

“This is an important step and a byproduct of the legal action we filed last summer. The agency indicated it would propose new rules to govern approving new applicants to manufacture marijuana for research, and these appear to be those rules,” says Sue Sisley, a researcher with the institution that filed the lawsuit.

For countries growing cannabis for research to comply with United Nations rules, they have to meet five requirements. Currently, the DEA follows three of the requirements, but the proposed rule would amend the agency’s regulations so that the DEA directly carries out the two remaining requirements.

They are; requiring cultivators to deliver their cannabis directly to a government agency in a timely manner, but no longer than four months after harvest, and; ensuring that the agency holds the “exclusive rights of importing, exporting, wholesale trading, and maintaining stocks of cannabis and cannabis resin,” except as it concerns medical marijuana preparations.

As per the DEA’s notice, the agency “may accept delivery and maintain possession of such crops at the registered location of the registered manufacturer authorized to cultivate cannabis consistent with the maintenance of effective controls against diversion.”

The notice states that in such cases, the DEA shall designate a secure storage mechanism at the registered location in which the DEA may maintain possession of the cannabis, and the DEA will control access to the stored cannabis.” It will also control importing, exporting, wholesale trading, and maintaining stocks, and it may “exercise its exclusive rights by authorizing the performance of such activities by appropriately registered persons.”

This news that more growers are about to be federally licensed is likely to be welcomed by sector players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) who would like to see more research being done by the academia and other entities whose findings will not be doubted by the public.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view the live presentations or ask questions.

To register now, visit http://cnw.fm/ArT8l

To view the full press release, visit http://cnw.fm/jc2vH

About Lexaria Bioscience

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way API’s enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactive molecules including nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and other molecules. Lexaria has licensed DehydraTECH to multiple companies for use in various oral application formats, including to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – No Borders, Inc.’s (NBDR) MediDent Supplies Announces New Stay at Home 15 Minute Rapid Result COVID-19 Blood Tests

No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and believes it will receive expedited approval due to a recent update to the FDA COVID-19 testing guidelines, which now include serological testing. “Our entire team is committed to deploying every ounce of effort we can to help America through this trying time,” MediDent Supplies CEO Joseph Snyder said in the news release. “Millions of people around the world have used these serological tests to identify COVID-19 antibodies in the blood and these tests will have a dramatic impact on America’s ability to scale national real time testing efforts with a proven, effective blood test.”

To view the full press release, visit http://cnw.fm/YpMt6

About No Borders Inc.

No Borders, Inc. (OTC: NBDR) is a multifaceted corporation specializing in the acquisition, creation, and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority and Intellectual Property ownership across its portfolio of assets. The Company’s portfolio of brands includes:

  • No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets (NoBordersNaturals.com).
  • No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security, and transparency (NoBordersLabs.com).
  • CBDLabChain.com a powerful, Patent Pending tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate of Authority (COA) on a blockchain technology platform.
  • No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (MediDentSupplies.com).

No Borders is headquartered in Arizona with resources in the U.S., South America, Asia, and Europe. For more information, visit the Company’s website at www.NBDR.co.

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at  http://cnw.fm/NBDR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.